Development of biopolymeric hybrid scaffold-based on AAc/GO/nHAp/TiO2 nanocomposite for bone tissue engineering: In-vitro analysis

Bone tissue engineering is an advanced field for treatment of fractured bones to re-store/regulate biological functions. Biopolymeric/bioceramic-based hybrid nanocomposite scaffolds are potential biomaterials for bone tissue because of biodegradable and biocompatible character-istics. We report synt...

Full description

Saved in:
Bibliographic Details
Main Authors: Aslam Khan, Muhammad Umar, Al-Arjan, Wafa Shamsan, Saad Binkadem, Mona, Mehboob, Hassan, Haider, Adnan, Ali Raza, Mohsin, Abd. Razak, Saiful Izwan, Hasan, Anwarul, Amin, Rashid
Format: Article
Published: MDPI AG 2021
Subjects:
Online Access:http://eprints.utm.my/id/eprint/95788/
http://dx.doi.org/10.3390/nano11051319
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bone tissue engineering is an advanced field for treatment of fractured bones to re-store/regulate biological functions. Biopolymeric/bioceramic-based hybrid nanocomposite scaffolds are potential biomaterials for bone tissue because of biodegradable and biocompatible character-istics. We report synthesis of nanocomposite based on acrylic acid (AAc)/guar gum (GG), nano-hydroxyapatite (HAp NPs), titanium nanoparticles (TiO2 NPs), and optimum graphene oxide (GO) amount via free radical polymerization method. Porous scaffolds were fabricated through freeze-drying technique and coated with silver sulphadiazine. Different techniques were used to investigate functional group, crystal structural properties, morphology/elemental properties, porosity, and mechanical properties of fabricated scaffolds. Results show that increasing amount of TiO2 in combination with optimized GO has improved physicochemical and microstructural properties, mechanical properties (compressive strength (2.96 to 13.31 MPa) and Young’s modulus (39.56 to 300.81 MPa)), and porous properties (pore size (256.11 to 107.42 µm) and porosity (79.97 to 44.32%)). After 150 min, silver sulfadiazine release was found to be ~94.1%. In vitro assay of scaffolds also exhibited promising results against mouse pre-osteoblast (MC3T3-E1) cell lines. Hence, these fabricated scaffolds would be potential biomaterials for bone tissue engineering in biomedical engineering.